|
|
|
|
||
Reminder from a PM on tilmanocept/Lymphoseek being top line in H&N..Independent trial: "Determine if panitumumab-IRDye800 can identify sentinel nodes with the >same accuracy< as technetium Tc 99m-labeled tilmanocept (Lymphoseek)." Stanford University, School of Medicine trial started Aug. 2019 |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
31045 | Re: Reminder from a PM on tilmanocept/Lymphoseek being top line in H&N..Independent trial: "Determine if panitumumab-IRDye800 can identify sentinel nodes with the >same accuracy< as technetium Tc 99m-labeled tilmanocept (Lymphoseek)." | dadeo55 | 0 | 11/18/2019 8:42:26 AM |